HomeTipranavirTipranavir + Amprenavir

Does Tipranavir Interact with Amprenavir?

Tipranavir and Amprenavir have a unknown drug interaction according to U.S. FDA drug labeling data. Protease Inhibitors (co-administered with 200 mg of ritonavir): Fosamprenavir ↓ Amprenavir Combining a protease inhibitor with APTIVUS/ritonavir is not recommended. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Tipranavir Class
Protease Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Tipranavir and your doctor is considering prescribing Amprenavir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tipranavir+💊 Amprenavir

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Protease Inhibitor
Drug B class
Source
FDA drug label - tipranavir

What this means in plain English

Protease Inhibitors (co-administered with 200 mg of ritonavir): Fosamprenavir ↓ Amprenavir Combining a protease inhibitor with APTIVUS/ritonavir is not recommended.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Tipranavir and Amprenavir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.